Elos Medtech AB: Elos Medtech Nomination Committee appointed for the 2022 Annual General Meeting
In accordance with the decision of the 2021 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than...
Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.
In accordance with the decision of the 2021 Annual General Meeting the Nomination Committee shall consist of not less than three and not more than...
Elos Medtech held its Extraordinary General Meeting ("EGM") on 13 August 2021. Due to the ongoing Covid-19 pandemic, the EGM was carried out throu...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
The shareholders of Elos Medtech AB (publ), corporate ID no. 556021-9650, headquartered in Gothenburg, are hereby invited to the Extraordinary Gen...
A STRONG QUARTER WITH CONTINUED GROWTH
April - June 2021
Net sales for the second quarter amounted to SEK 181.0 (118.3) million, an in...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
Flaggningsmeddelande i Elos Medtech AB
Anmälan om förvärv eller överlåtelse av finansiella instrument.
Emittent
...
The board of directors unanimously recommends the shareholders to accept the offer from TA Associates.
This statement is made by the board of d...
Today, June 11, 2021, TA Associates through EM Intressenter AB ("TA Associates") announced a public offer of SEK 215 in cash per share to the shar...
Elos Medtech AB (publ) has noted the recent share price development. The Board of Directors announces that, commencing a little more than two week...
Elos Medtechs årsstämma hölls måndagen den 3 maj 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin, geno...
A POSITIVE START TO THE YEAR
January - March 2021
Net sales for the first quarter amounted to SEK 171.2 (158.9) million, an increase ...
Elos Medtech's Swedish language Annual and Sustainability Report for the fiscal year 2020 has been published and is now available on the Group's w...
Aktieägarna i Elos Medtech AB (publ), org.nr 556021-9650, med säte i Göteborg, kallas härmed till årsstämma måndagen den 3 maj 2021.
Mot bakg...
STRONG CONCLUSION TO THE YEAR
October - December
Net sales for the fourth quarter amounted to SEK 154.8 (158.3) million, a decrease of...
Elos Medtech in Skara specializes in injection molding in high-tech polymers with high quality. The company has built up a highly automated produc...
Tina Friis-Poulsen has been appointed to succeed Soren Olesen in leading Elos Medtech in Gorlose, Denmark. Tina Friis-Poulsen has been with the co...